Literature DB >> 7614178

A longitudinal follow-up of salivary secretion in bone marrow transplant patients.

G Chaushu1, S Itzkovitz-Chaushu, E Yefenof, S Slavin, R Or, A A Garfunkel.   

Abstract

Salivary gland dysfunction is a common sequela of the bone marrow transplantation procedure. We determined the effect of different bone marrow transplantation protocols on parotid salivary flow rate. Salivary secretion was substantially reduced during conditioning of all the recipients. A gradual flow rate reconstitution could be detected as soon as a few days after the bone marrow transplantation. Eight patients conditioned with total lymph node irradiation and chemotherapy or chemotherapy alone displayed earlier and complete recovery of saliva secretions 2 to 5 months after the grafting. Recovery was delayed and incomplete when total body irradiation was added to the conditioning regimen (seven patients). Six of these patients also developed graft-versus-host disease. The results suggest that total body irradiation induces irreversible damage to the parotid glands resulting in profound xerostomia followed by opportunistic infections. Chemotherapy with or without total lymph node irradiation does not induce such damage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614178     DOI: 10.1016/s1079-2104(05)80276-8

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  5 in total

1.  Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation.

Authors:  Matin M Imanguli; Jane C Atkinson; Sandra A Mitchell; Daniele N Avila; Rachel J Bishop; Edward W Cowen; Manuel B Datiles; Frances T Hakim; David E Kleiner; Michael C Krumlauf; Steven Z Pavletic
Journal:  Biol Blood Marrow Transplant       Date:  2010-03-28       Impact factor: 5.742

Review 2.  A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life.

Authors:  S B Jensen; A M L Pedersen; A Vissink; E Andersen; C G Brown; A N Davies; J Dutilh; J S Fulton; L Jankovic; N N F Lopes; A L S Mello; L V Muniz; C A Murdoch-Kinch; R G Nair; J J Napeñas; A Nogueira-Rodrigues; D Saunders; B Stirling; I von Bültzingslöwen; D S Weikel; L S Elting; F K L Spijkervet; M T Brennan
Journal:  Support Care Cancer       Date:  2010-03-17       Impact factor: 3.603

3.  Post-allogeneic Hematopoietic Stem Cell Transplantation (HSCT) changes in inorganic salivary components.

Authors:  C C Boer; M E P Correa; L M A Tenuta; C A Souza; A C Vigorito
Journal:  Support Care Cancer       Date:  2015-02-05       Impact factor: 3.603

Review 4.  Reconstitution of the immune system after hematopoietic stem cell transplantation in humans.

Authors:  Jan Storek; Michelle Geddes; Faisal Khan; Bertrand Huard; Claudine Helg; Yves Chalandon; Jakob Passweg; Eddy Roosnek
Journal:  Semin Immunopathol       Date:  2008-10-24       Impact factor: 9.623

Review 5.  Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT).

Authors:  Sharon Elad; Judith E Raber-Durlacher; Michael T Brennan; Deborah P Saunders; Arno P Mank; Yehuda Zadik; Barry Quinn; Joel B Epstein; Nicole M A Blijlevens; Tuomas Waltimo; Jakob R Passweg; M Elvira P Correa; Göran Dahllöf; Karin U E Garming-Legert; Richard M Logan; Carin M J Potting; Michael Y Shapira; Yoshihiko Soga; Jacqui Stringer; Monique A Stokman; Samuel Vokurka; Elisabeth Wallhult; Noam Yarom; Siri Beier Jensen
Journal:  Support Care Cancer       Date:  2014-09-05       Impact factor: 3.603

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.